Table 4 Solicited local adverse events within 14 days after vaccination
Local reactions, No. (%) | Group 1 (N = 151) | Group 2 (N = 149) | Group 3 (N = 148) | p-value |
|---|---|---|---|---|
Pain | ||||
None | 55 (36.4) | 65 (43.6) | 68 (45.9) | 0.20 |
Mild | 84 (55.6) | 73 (49.0) | 76 (51.4) | |
Moderate | 12 (7.9) | 10 (6.7) | 3 (2.0) | |
Severe | 0 (0) | 1 (0.7) | 1 (0.7) | |
Tenderness | ||||
None | 55 (36.4) | 54 (36.2) | 59 (39.9) | 0.09 |
Mild | 85 (56.3) | 82 (55.0) | 86 (58.1) | |
Moderate | 11 (7.3) | 10 (6.7) | 3 (2.0) | |
Severe | 0 (0) | 3 (2.0) | 0 (0) | |
Redness diameter | ||||
0 mm | 99 (65.6) | 108 (72.5) | 117 (79.0) | 0.12 |
1–9 mm | 12 (7.9) | 9 (6.0) | 9 (6.1) | |
≥ 10 mm | 40 (26.5) | 32 (21.5) | 22 (14.9) | |
Swelling diameter | ||||
0 mm | 111 (73.5) | 114 (76.5) | 123 (83.1) | 0.32 |
1–9 mm | 14 (9.3) | 15 (10.1) | 9 (6.1) | |
≥ 10 mm | 26 (17.2) | 20 (13.4) | 16 (10.8) | |